www.clicktherapeutics.com

Click Therapeutics Stock

Company Profile:

Click Therapeutics is a biotechnology company that develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs.

Sign up for SecondMarket® to view the market and buy or sell Click Therapeutics Stock

Buy + Sell

24 Months 12 Months 6 Months

Click Therapeutics Stock Price Per Share

Click Therapeutics Funding

Sign up to gain insights into Click Therapeutics funding history, including the funding round, time period, and amount raised.

Date	Financing Round	Amount	Price per share*	Valuation*
Mar 17, 2025	Series C	8.58M	Price	Valuation
Mar 17, 2025	Series C	40.00M	Price	Valuation
May 20, 2024	Series B	3.00M	Price	Valuation
Oct 21, 2021	Series B	52.12M	Price	Valuation
Jun 15, 2018	Series A	17.26M	Price	Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D®

See Click Therapeutics Valuations + Financials

*Sample data + company shown for illustrative purposes only

Gain insights Into Click Therapeutics Stock Valuation + Share Prices

View real-time Tape D® data on Click Therapeutics stock including most recent valuation and historical share price information.

Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.

Get Started

Leverage Your Equity to Help Achieve More.

Click Therapeutics Management Team

Chief Executive Officer

David B. Klein
Chief Legal Officer

Tarique Collins
Chief Financial Officer

Randall Stanicky
Chief Strategy Officer

Austin C. Speier
Chief Medical Officer

Shaheen Lakhan
Chief People Officer

Usha Dantu
Chief Commercial Officer

Richard DeNunzio
Chief Technology Officer

Han Chiu

Click Therapeutics Major Investors

Silicon Valley Bank
Sanofi Ventures
Ridgetop Health
Revelation Partners
K2 HealthVentures
Hikma Ventures
Health Catalyst Capital
Accelmed

Learn More About Click Therapeutics Stock

Buy Click Therapeutics Stock

Click Therapeutics stock does not trade on public stock exchanges. Click Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Click Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Click Therapeutics Stock

Click Therapeutics Stock does not trade on public stock exchanges. In order to sell Click Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Click Therapeutics Stock Price

Nasdaq Private Market estimates that Click Therapeutics price per share was $4.89 last month. This Click Therapeutics share value estimate (known as the Tape D™ price) is based on market activity, publicly-sourced valuation data, and other proprietary information. With Tape D premium for investors, you can get visibility into the Click Therapeutics share price today and the factors driving Click Therapeutics valuation estimates. Learn more about premium data here.

Read more about private company stock prices: Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price

Click Therapeutics Stock Ticker Symbol

There is no ticker symbol for Click Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Click Therapeutics Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Click Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Are You Eligible to Sell Private Company Stock?

Criteria to Buy or Invest in Click Therapeutics Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Click Therapeutics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Click Therapeutics Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Click Therapeutics IPO

Click Therapeutics is a private company and has not had an IPO. There is currently no Click Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Click Therapeutics IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell Click Therapeutics Stock

Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.